Piotr Stępnicki

What are the challenges with multi-targeted drug design for complex diseases?

Agata Zięba, Piotr Stępnicki, Dariusz Matosiuk et al. · Expert Opinion on Drug Discovery · 2022 · 45 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Synthesis, pharmacological and structural studies of 5-substituted-3-(1-arylmethyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as multi-target ligands of aminergic GPCRs

Magda Kondej, Tomasz M. Wróbel, Andrea Silva et al. · European Journal of Medicinal Chemistry · 2019 · 26 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

N-(3-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}propyl)-1H-indazole-3-carboxamide (D2AAK3) as a potential antipsychotic: In vitro, in silico and in vivo evaluation of a multi-target ligand

Agnieszka A. Kaczor, Katarzyna M. Targowska‐Duda, Piotr Stępnicki et al. · Neurochemistry International · 2021 · 15 citations

Medicine, Medicinal Chemistry, Pharmacology +10

Multitarget Derivatives of D2AAK1 as Potential Antipsychotics: The Effect of Substitution in the Indole Moiety

Magda Kondej, Tomasz M. Wróbel, Katarzyna M. Targowska‐Duda et al. · ChemMedChem · 2022 · 10 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17